Both in Pharmaceuticals
Inovio Pharmaceuticals vs BridgeBio Oncology Therapeutics
Over the past year INO returned −24.4% and BBOT returned −81.2%; their daily moves had a correlation of -0.06.
INO −24.4% BBOT −81.2%Growth of $1, one year, split-adjusted
| Metric | INO | BBOT |
|---|---|---|
| Price | $1.89 | $2.31 |
| Market cap | $195.4M | $185.2M |
| Today | +213.75% | −11.83% |
| 1 month | +62.9% | −40.6% |
| 6 months | +65.8% | −72.7% |
| Year to date | +8.6% | −81.5% |
| 1 year | −19.9% | −80.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $36.7M | $225.7M |
| Dividend yield | — | — |
| Volatility (60d) | 260.0% | 87.8% |
| Short % of float | 26.3% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).